Medicine

Y. Nozaki, A. Yamamoto, Daisuke Tomita, Tomoko Hyodo, Hayato Kaida, Kazunari Ishii, K. Kinoshita

2026.5.8Modern Rheumatology

DOI: 10.1093/mr/roag037

Abstract

OBJECTIVES To compare diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) with ^18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for assessing disease activity in large-vessel vasculitis (LVV), and to evaluate whether segment-level analysis provides complementary information beyond global grading.

METHODS We enrolled 25 patients with LVV (Takayasu arteritis [TAK], n = 11; giant cell arteritis [GCA], n = 14). Two blinded readers graded 11 arterial territories (18 segments) on a four-point visual scale for DWIBS and FDG-PET/CT. Global imaging grades were calculated as segment-averaged means. Correlations with serum C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were assessed.

RESULTS Global mean DWIBS grades correlated significantly with FDG-PET/CT grades (r = 0.72) and with CRP levels (r = 0.53). Territory-level mapping revealed diffuse central aortic involvement in GCA, whereas TAK showed more focal and segment-limited patterns. DWIBS demonstrated lower sensitivity in motion-prone regions but appeared to better reflect clinical activity and more frequently detected subclavian artery involvement in TAK compared with FDG-PET/CT. Residual vascular signals were also observed in some patients classified as being in clinical remission.

CONCLUSIONS DWIBS shows good agreement with FDG-PET/CT and provides a radiation- and contrast-free approach for assessing LVV. Global mean grades alone showed limited discriminatory power and may underestimate disease activity in focal or segment-limited involvement. Integrating segment-level imaging findings with clinical and laboratory markers may improve assessment of disease activity. Multicenter validation and longitudinal studies are warranted.

Citation format

NOZAKI, Y., et al. Exploratory comparison of diffusion-weighted whole-body imaging with background body signal suppression and 18F-FDG PET/CT for assessing disease activity in large-vessel vasculitis. Modern Rheumatology, 2026.